Advances in oncology after the 2024 European Society for Medical Oncology (ESMO) congress

Dawid Sigorski, Małgorzata Osmola, Bartosz Spławski, Sylwia Tabor, Mirosława Püsküllüoğlu, Renata Pacholczak-Madej, Edyta Hunia-Prejsnar, Michał Gola, Michał Wilk, Agnieszka Markiewicz, Joanna Kiszka

Online first

Conference report / Report

Role of radiotherapy to the primary lesion in metastatic non-small cell lung cancer patients after first-line systemic therapy — a prospective randomized phase II study

Ahmed Sohaib, Eman Abdelrazek, Enas El-Khouly, Yostena Mekhail, Reham Ahmed Abdelaziz

Online first

Research paper

T cell immunoglobulin and mucin-domain containing-3 (TIM-3), lymphocyte-activation gene 3 (LAG-3), and T cell immunoreceptor with immunoglobulin and ITIM domain (TIGIT) — an update on emerging negative immune checkpoints in cancer treatment

Natalia Krzyżanowska

Online first

Review paper

Multiple primary malignancies and cancer during pregnancy — a case of two rare consecutive conditions

Izabela Dymanowska, Karolina Frankowska, Natalia Olbrot, Marika Jerzak, Paulina Miciuda, Elżbieta Witt, Grzegorz Polak

Online first

Case report

Optimization of systemic treatment in patients with bladder, ureter, and renal pelvis cancer — expert opinion of the Polish Society of Clinical Oncology

Piotr Wysocki, Maciej Krzakowski, Łukasz Kwinta, Jakub Kucharz, Iwona Skoneczna, Paweł Wiechno

Online first

Guidelines / Expert consensus

Combined immunotherapy in lung cancer — a case report highlighting immune response dynamics and clinical success

Tomasz Jankowski, Natalia Krzyżanowska, Kamila Wojas-Krawczyk, Paweł Krawczyk, Janusz Milanowski

Online first

Case report